Brewer's spent yeast improves human gut microbiota and ameliorates clinical blood parameters: A randomized, double-blind, placebo-controlled trial

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Regional de Blumenau-
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.creatorHorn, Priscila Aparecida-
Autor(es): dc.creatorZeni, Ana Lúcia Bertarello-
Autor(es): dc.creatorHerkenhoff, Marcos Edgar-
Autor(es): dc.creatorCurbani, Luana-
Autor(es): dc.creatorPereira Gonçalves, Gustavo Henrique-
Autor(es): dc.creatorRutkoski, Camila Fatima-
Autor(es): dc.creatorIsrael, Nicole Grasmuk-
Autor(es): dc.creatorde Almeida, Eduardo Alves-
Data de aceite: dc.date.accessioned2025-08-21T22:31:32Z-
Data de disponibilização: dc.date.available2025-08-21T22:31:32Z-
Data de envio: dc.date.issued2025-04-29-
Data de envio: dc.date.issued2024-11-30-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1016/j.bcdf.2024.100442-
Fonte completa do material: dc.identifierhttps://hdl.handle.net/11449/301915-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/301915-
Descrição: dc.descriptionThis study investigated the effects of Brewer's spent yeast (BSY) on blood clinical parameters, changes in the intestinal production of short-chain fatty acids, and microbiota composition. A double-blind, placebo-controlled, randomized clinical trial intervention study was conducted on 50 healthy volunteers for four weeks, in which participants took a pill containing 500 mg of BSY or an equivalent placebo pill containing maltodextrin. After the intervention, plasma total cholesterol level decreased, and fecal short-chain fatty acids in the form of butyric acid and acetic acid increased in the BSY group but not in the control group. Microbiome analysis by qPCR showed a higher abundance of healthy associations of Lactobacillus and Firmicutes in the BSY-T group, suggesting that the dietary metabolic response may depend on the specific composition of the gut microbiota. These results indicate the potential positive impact of Brewer's yeast on metabolic health and intestinal microbiota.-
Descrição: dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)-
Descrição: dc.descriptionPrograma de Pós-Graduação em Engenharia Ambiental Universidade Regional de Blumenau, Santa Catarina-
Descrição: dc.descriptionLaboratório de Avaliação de Substâncias Bioativas Departamento de Ciências Naturais Universidade Regional de Blumenau, Santa Catarina-
Descrição: dc.descriptionDepartment of Chemical and Biological Sciences Institute of Biosciences of Botucatu São Paulo State University (UNESP), SP-
Descrição: dc.descriptionDepartment of Chemical and Biological Sciences Institute of Biosciences of Botucatu São Paulo State University (UNESP), SP-
Descrição: dc.descriptionCNPq: 313503/2021-4-
Idioma: dc.languageen-
Relação: dc.relationBioactive Carbohydrates and Dietary Fibre-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectBrewer's spent yeast-
Palavras-chave: dc.subjectCholesterol-
Palavras-chave: dc.subjectClinical trial-
Palavras-chave: dc.subjectGlucans-
Palavras-chave: dc.subjectGut microbiota-
Palavras-chave: dc.subjectHealthy humans-
Palavras-chave: dc.subjectPrebiotic-
Palavras-chave: dc.subjectRandomized-
Palavras-chave: dc.subjectShort chain fatty acids-
Título: dc.titleBrewer's spent yeast improves human gut microbiota and ameliorates clinical blood parameters: A randomized, double-blind, placebo-controlled trial-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.